✦ LIBER ✦

253 ASSOCIATION OF HOST PHARMACODYNAMIC EFFECTS AND VIROLOGIC RESPONSE TO PEGINTERFERON ALFA-2A/RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS C

✍ Scribed by R.T. Chung; A. Di Bisceglie; F.F. Poordad; T. Hassanein; X. Zhou; E. Lentz; A. Prabhakar; F.M. Hamzeh

Book ID: 117378339
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 68 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(10)60255-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Association of host pharmacodynamic effe

Association of host pharmacodynamic effects with virologic response to pegylated interferon alfa-2a/ribavirin in chronic hepatitis C

✍ Raymond T. Chung; Fred F. Poordad; Tarek Hassanein; Xiaolei Zhou; Ellen Lentz; A 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 773 KB

Patients receiving therapy for chronic hepatitis C virus (HCV) infection frequently experience cytopenias and weight loss. We retrospectively assessed the pharmacodynamic effects of pegylated interferon (PEG-IFN) alfa-2a and ribavirin by evaluating the relationship between changes in hematologic par

Early virologic response to treatment wi

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C

✍ Gary L. Davis; John B. Wong; John G. McHutchison; Michael P. Manns; Joann Harvey 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB

Early virologic response and IL28B polym

Early virologic response and IL28B polymorphisms in patients with chronic hepatitis C genotype 3 treated with peginterferon alfa-2a and ribavirin

✍ Thomas-Matthias Scherzer; Harald Hofer; Albert Friedrich Staettermayer; Karoline 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 801 KB

Early virologic response after peginterf

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C

✍ A. M. Di Bisceglie; R. H. Ghalib; F. M. Hamzeh; V. K. Rustgi 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 547 KB

PIN92 Patient Reported Outcomes Among Ch

PIN92 Patient Reported Outcomes Among Chronic Hepatitis C Patients Re-Treated with Peginterferon Alfa-2A/Ribavirin After Non-response to Peginterferon Alfa-2B/Ribavirin in Spain

✍ A. Olveira; D. Rincon; M. Diago; J. Crespo; J.L. Calleja; J. Salmeron; R. Andrad 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Predicting sustained virological respons

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin

✍ Peter Ferenci; Michael W. Fried; Mitchell L. Shiffman; Coleman I. Smith; George 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 182 KB